Inactive Instrument

Analyst Reco. BioScrip Inc Nasdaq

Equities

US09069N1081

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

Jefferies Adjusts Price Target on Option Care Health to $38 From $36, Maintains Buy Rating	Mar. 04	MT
Deutsche Bank Adjusts Option Care Health Price Target to $36 From $35, Maintains Buy Rating	Feb. 23	MT
Barrington Boosts Price Target on Option Care Health to $38 From $35, Maintains Outperform Rating	Feb. 23	MT
Deutsche Bank Cuts Option Care Health Price Target to $35 From $39, Maintains Buy Rating	23-10-26	MT
Barrington Cuts Price Target on Option Care Health to $35 From $41 After Solid Q3 Earnings, Keeps Outperform Rating	23-10-26	MT
JPMorgan Cuts Price Target on Option Care Health to $44 From $46, Maintains Overweight Rating	23-10-18	MT
Deutsche Bank Adjusts Option Care Health Price Target to $39 From $32.50, Maintains Buy Rating	23-07-31	MT
Barrington Ups Price Target on Option Care Health to $41 From $34, Maintains Outperform Rating	23-07-28	MT
Deutsche Bank Adjusts Option Care Health Price Target to $32.50 From $39, Maintains Buy Rating	23-05-05	MT
Jefferies Reinstates Option Care Health at Buy With $38 Price Target	23-02-27	MT
Barrington Research Adjusts Option Care Health's Price Target to $38 From $37, Keeps Outperform Rating	22-10-28	MT
Goldman Sachs Adjusts Option Care Health's Price Target to $40 From $31, Maintains Buy Rating	22-08-22	MT
Barrington Research Raises Option Care Health's Price Target to $37 From $33, Maintains Outperform Rating	22-07-28	MT
Deutsche Bank Adjusts Option Care Health Price Target to $39 From $32, Maintains Buy Rating	22-04-29	MT
Barrington Raises Option Care Health's Price Target to $33 From $31, Maintains Outperform Rating	22-04-29	MT
Barrington Adjusts Price Target on Option Care Health to $31 From $28 After Q3 Earnings Beat, Maintains Outperform Rating	21-11-05	MT
Deutsche Bank Adjusts Option Care Health PT to $32 From $23.50, Maintains Buy Rating	21-11-05	MT
OPTION CARE HEALTH : Goldman Sachs Adjusts Option Care Health PT to $30 From $26, Maintains Buy Rating	21-09-08	MT
OPTION CARE HEALTH : Lake Street Adjusts Price Target on Option Care Health to $35 From $27, Maintains Buy Rating	21-08-30	MT
OPTION CARE HEALTH : Canaccord Genuity Adjusts Price Target on Option Care Health to $24 From $22, Reiterates Buy Rating	21-08-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. BioScrip Inc Nasdaq

Equities

US09069N1081

Analyst Reco.

Filters